Evidence map›Paper›PMID 31285283›Full record

ArticleMolecular & cellular proteomics : MCP2019

Canine Bone Marrow-derived Mesenchymal Stem Cells: Genomics, Proteomics and Functional Analyses of Paracrine Factors.

Filip Humenik, Dasa Cizkova, Stefan Cikos, Lenka Luptakova, Aladar Madari, Dagmar Mudronova, Maria Kuricova, Jana Farbakova, Alexandra Spirkova, Eva Petrovova and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Filip Humenik‡University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, Košice 041 81, Slovakia.
Dasa Cizkova‡University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, Košice 041 81, Slovakia; §Institute of Neuroimmunology, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava 845 10, Slovakia; ¶Université Lille, INSERM, U1192 - Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse-PRISM, F-59000 Lille, France. Electronic address: cizkova.dasa@gmail.com.
Stefan Cikos‖Institute of Animal Physiology, Centre of Biosciences of the Slovak Academy of Sciences, Šoltésovej 4-6, Košice 04001, Slovakia.
Lenka Luptakova‡University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, Košice 041 81, Slovakia.
Aladar Madari‡University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, Košice 041 81, Slovakia.
Dagmar Mudronova‡University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, Košice 041 81, Slovakia.
Maria Kuricova‡University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, Košice 041 81, Slovakia.
Jana Farbakova‡University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, Košice 041 81, Slovakia.
Alexandra Spirkova‖Institute of Animal Physiology, Centre of Biosciences of the Slovak Academy of Sciences, Šoltésovej 4-6, Košice 04001, Slovakia.
Eva Petrovova‡University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, Košice 041 81, Slovakia.
Martin Cente§Institute of Neuroimmunology, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava 845 10, Slovakia.
Zuzana Mojzisova‡University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, Košice 041 81, Slovakia.
Soulaimane Aboulouard¶Université Lille, INSERM, U1192 - Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse-PRISM, F-59000 Lille, France.
Adriana-Natalia Murgoci§Institute of Neuroimmunology, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava 845 10, Slovakia; ¶Université Lille, INSERM, U1192 - Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse-PRISM, F-59000 Lille, France.
Isabelle Fournier¶Université Lille, INSERM, U1192 - Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse-PRISM, F-59000 Lille, France.
Michel Salzet¶Université Lille, INSERM, U1192 - Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse-PRISM, F-59000 Lille, France. Electronic address: michel.salzet@univ-lille.fr.
University of Veterinary Medicine in Košice · SKInserm · FRSlovak Academy of Sciences · SK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adult stem cells have become prominent candidates for treating various diseases in veterinary practice. The main goal of our study was therefore to provide a comprehensive study of canine bone marrow-derived mesenchymal stem cells (BMMSC) and conditioned media, isolated from healthy adult dogs of different breeds. Under well-defined standardized isolation protocols, the multipotent differentiation and specific surface markers of BMMSC were supplemented with their gene expression, proteomic profile, and their biological function. The presented data confirm that canine BMMSC express important genes for differentiation toward osteo-, chondro-, and tendo-genic directions, but also genes associated with angiogenic, neurotrophic, and immunomodulatory properties. Furthermore, using proteome profiling, we identify for the first time the dynamic release of various bioactive molecules, such as transcription and translation factors and osteogenic, growth, angiogenic, and neurotrophic factors from canine BMMSC conditioned medium. Importantly, the relevant genes were linked to their proteins as detected in the conditioned medium and further associated with angiogenic activity in chorioallantoic membrane (CAM) assay. In this way, we show that the canine BMMSC release a variety of bioactive molecules, revealing a strong paracrine component that may possess therapeutic potential in various pathologies. However, extensive experimental or preclinical trials testing canine sources need to be performed in order to better understand their paracrine action, which may lead to novel therapeutic strategies in veterinary medicine.

Indexed as

Paracrine CommunicationAdipogenesisAnimalsBiomarkersBone Marrow CellsCell DifferentiationCell LineageChick EmbryoChorioallantoic MembraneCulture Media, ConditionedDogsGene Expression RegulationMaleMesenchymal Stem CellsNeovascularization, PhysiologicOsteogenesisBiomarkersCulture Media, ConditionedProteinsBiomarker: PrognosticBone Marrow-Derived Stem CellsCanineInduced Pluripotent Stem CellsProgenitor CellsProteomicRegenerative MedicineSecretomeSpinal Cord InjuryStem Cells

Identifiers

PMID31285283
PMCPMC6731083
OpenAlexW2959364249

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.